Intracavernosal injection of platelet rich plasma for treatment of erectile dysfunctio
- Conditions
- Health Condition 1: N529- Male erectile dysfunction, unspecified
- Registration Number
- CTRI/2023/09/058110
- Lead Sponsor
- All India Institute of Medical Sciences Raipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Male patients aged 21-75 years
2. Patients with well-established chronic ED for at least 3 months
3. IIEF-EF score 11-25 at screening (even if taking a single PDE5I)
4. sexually active in a heterosexual stable partnership for at least 3 months will be considered for study
5. Patients must be willing to comply with the key requests of the trial, namely to maintain regular sexual activities during the entire course of the trial with a mean frequency of sexual activities of at least once per week and comply with study related tests and procedures
6. must give up any other EF enhancing treatment, including hormonal (T) replacement therapy with study entrance.
1. Previous surgery of penile fracture/ hypospadias/penile reconstructive surgery. 2. history of significant psychiatric disease/BPD
3. untreated hypogonadism
4. uncontrolled DM (HBA1c > 9%)
5. patients using intra-cavernosal injection of vasoactive substances for ED
6. developing priapism during before or during study period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method